bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026

Go back to bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
(NASDAQ: BIAF) Delayed: 3.57 -0.09 (2.46%)
Previous Close $3.66    52 Week High $ 
Open $3.68    52 Week Low $ 
Day High $3.69    P/E N/A 
Day Low $3.54    EPS $ 
Volume 61,866       

(NASDAQ: BIAFW) Delayed: 0.32 --0 (-0%)
Previous Close $0.32    52 Week High $ 
Open $0.32    52 Week Low $ 
Day High $0.32    P/E N/A 
Day Low $0.32    EPS $ 
Volume 1,362,235